-
Enlivex Announces Trial Initiation of Allocetra in COVID-19 Patients
americanpharmaceuticalreview
May 12, 2020
Enlivex Therapeutics announced an investigator-initiated multi-center Phase II clinical trial of Allocetra in COVID-19 patients has commenced.
-
FDA Continues to Combat Fraudulent COVID-19 Medical Products
americanpharmaceuticalreview
May 12, 2020
The U.S. Food and Drug Administration (FDA) is providing an update on the agency’s efforts to combat the extremely concerning actions by companies and individuals ...
-
Triple antiviral drug combination shows early promise for treating COVID-19 in Phase II trial
europeanpharmaceuticalreview
May 12, 2020
A Phase II clinical trial has shown that a two-week course of interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within seven days of showing COVID-19 symptoms, is safe and effective.
-
Sorrento and Mount Sinai to develop antibody cocktail against Covid-19
pharmaceutical-technology
May 12, 2020
Sorrento Therapeutics has collaborated with Mount Sinai Health System to develop an antibody cocktail, COVI-SHIELD, for the potential treatment of Covid-19.
-
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics,
expresspharma
May 12, 2020
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options, two proposals on drug repurposing and 14 projects which are categorised as preventive interventions.
-
Hamdard Laboratories launches digital campaign about Covid-19 preventive measures
expresspharma
May 12, 2020
As the nation stands united to fight the Covid-19 pandemic, Hamdard Laboratories (Medicine Division) announces the launch of its new campaign #MainDarpokHoon to encourage people to stay indoors and take preventive measures to stay healthy and safe.
-
Report Says MMR Vax Campaigns May Protect Against COVID-19
contractpharma
May 12, 2020
Nearly all countries with few or no deaths from COVID-19 have also had large measles-rubella vaccination programs in recent years.
-
Sterling Begins HCQ Production in UK
contractpharma
May 12, 2020
Partners with Accord Healthcare for the manufacture of potential COVID-19 treatment.
-
FDA Grants EUA for Cardiac Monitoring in COVID-19 Patients
americanpharmaceuticalreview
May 11, 2020
VitalConnect® announced it was granted Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) as part of the response to the COVID-19 pandemic.
-
Evelo, Rutgers, RWJ Submit IND for Study of EDP1815 as COVID-19 Treatment
americanpharmaceuticalreview
May 11, 2020
Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital (RWJ) announced the submission of an Investigational New Drug (IND) application.